Ya I Levin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
The results of the study on the efficacy and safety of the valdoxan (agomelatine) in the treatment of patients with major depressive disorder and insomnia are presented. The study included 64 patients (mean age 45.0±11.7 years). Agomelatine was given in dosage of 25--50 mg for 6 weeks. The following scales were used: HAMD-21, HADS, subjective sleep(More)
  • 1